Victoria Gutgarts, MD
Assistant Attending Physician
Acute Kidney Injury; Chronic Kidney Disease; Electrolyte Abnormalities; Kidney Injury Related to Bone Marrow Transplantation and Chemotherapy
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Contact and Location
Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
MD, SUNY Downstate Medical Center
Internal Medicine - Montefiore Medical Center/Albert Einstein College of Medicine
Nephrology - Weill Cornell Medical Center/ NewYork-Presbyterian; Onconephrology - Memorial Sloan Kettering Cancer Center
Internal Medicine; Nephrology
I am a board-certified kidney specialist. I treat a spectrum of conditions varying from acute to chronic kidney disease and electrolyte abnormalities. After my nephrology training at Weill Cornell Medical Center, I spent additional time training at Memorial Sloan Kettering Cancer Center, where I subspecialized in onconephrology to sharpen my understanding of kidney issues associated with cancer. During my inpatient and outpatient consultations, I strive to provide clear explanations and answer any questions to the best of my ability. I aim to comfort my patients and instill a sense of trust and teamwork with them.
I am a member of several nephrology societies, including the American Society of Nephrology. I have attended and presented at national conferences. My current research interest is kidney injury in people who have undergone bone marrow transplantation. I am also interested in identifying early markers of kidney injury through novel urine biomarkers. I am always eager to collaborate with my oncology colleagues at Memorial Sloan Kettering with the ultimate goal of performing meaningful and thoughtful research to help our patients.
I aim to comfort my patients and instill a sense of trust and teamwork with them.
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Victoria Gutgarts discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.